{"id":"CHEMBL101","canonicalSmiles":"CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O","inchiKey":"VYMDGNCVAMGZFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLBUTAZONE","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Hematological toxicity"," Misuse"],"year":1985},"tradeNames":["Antadol","Azolid","Butacote","Butaject","Butazolidin","Elmedal","Equiphar","Phenylbutazone","Pro-Bute"],"synonyms":["Ambene","Artrizin","Bizolin","Butadion","Butadiona","Butapirazol","Butatron","Butoz","Buzon","Diphebuzol","Diphenylbutazone","Ecobutazone","Equipalazone","Exrheudon n","Fenibutazona","Fenibutol","Fenylbutazon","Flexazone","G-13871","Intrabutazone","Intrazone","Mepha-butazon","NSC-25134","Phebuzine","Phenylbutazone","Phenyzene","R-3-ZON","Robizone-v","Shigrodin","Tevcodyne","Uzone","Zolaphen"],"crossReferences":{"PubChem":["104171220","104171221","11111674","144203793","144203794","144209007","144213080","170465040","17389760","26747057","26751573","50104199","56436656","85231197","855958","90341773"],"TG-GATEs":["11"],"Wikipedia":["Phenylbutazone"],"drugbank":["DB00812"],"chEBI":["48574"]},"childChemblIds":["CHEMBL3137687"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["HP_0002829","HP_0003326","EFO_0005755"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and has 3 approved indications. It was withdrawn in Germany  in 1985 due to Hematological toxicity and  Misuse."}
{"id":"CHEMBL101541","canonicalSmiles":"Nc1nc2ncc(CO)nc2c(=O)[nH]1","inchiKey":"XGWIBNWDLMIPNF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL101541","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03197"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1027","canonicalSmiles":"Cc1ccsc1C(=CCCN1CCC[C@@H](C(=O)O)C1)c1sccc1C","inchiKey":"PBJUNZJWGZTSKL-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIAGABINE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gabitril"],"synonyms":["A-70569-1","ABBOTT-70569","ABBOTT-70569 FREE BASE","ABBOTT-70569-1","ABBOTT-705691 FREE BASE","ABT-569","ABT-569 FREE BASE","Gabitril","NNC-05-0328","NNC-050328 FREE BASE","NO-05-0328","NO-050328 FREE BASE","Tiagabine"],"crossReferences":{"DailyMed":["tiagabine%20hydrochloride"],"PubChem":["26758048"],"Wikipedia":["Tiagabine"],"drugbank":["DB00906"],"chEBI":["9586"]},"childChemblIds":["CHEMBL1695"],"linkedTargets":{"rows":["ENSG00000157103"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_1001892","EFO_0002610","EFO_0000474","EFO_1001917","HP_0001250","MONDO_0007079","EFO_0005230","EFO_0003918"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for epilepsy and seizure and has 6 investigational indications."}
{"id":"CHEMBL1054","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O","inchiKey":"LMJSLTNSBFUCMU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICHLORMETHIAZIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Metahydrin","Naqua","Trichlorex","Trichlormas","Trichlormethiazide"],"synonyms":["NSC-61560","Trichlormethiazide","Trichloromethiazide"],"crossReferences":{"PubChem":["144203972","170464812","56422224","855703"],"Wikipedia":["Trichlormethiazide"],"drugbank":["DB01021"],"chEBI":["9683"]},"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960 and is indicated for cardiovascular disease."}
{"id":"CHEMBL1075","canonicalSmiles":"CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2","inchiKey":"FUBVWMNBEHXPSU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MORICIZINE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ethmozine"],"synonyms":["EN-313","EN-313 FREE BASE","Ethmozine","Moracizine","Moricizine"],"crossReferences":{"PubChem":["11112721","174006664","50086819"],"Wikipedia":["Moracizine"],"drugbank":["DB00680"],"chEBI":["6997"]},"childChemblIds":["CHEMBL1200334"],"linkedTargets":{"rows":["ENSG00000153253","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0000275","EFO_0004269"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and is indicated for cardiac arrhythmia and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1089","canonicalSmiles":"NNCCc1ccccc1","inchiKey":"RMUCZJUITONUFY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PHENELZINE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Nardil","Phenelzine"],"crossReferences":{"DailyMed":["phenelzine%20sulfate"],"PubChem":["11111653","11111654","174006798","50111200","90341694"],"Wikipedia":["Phenelzine"],"drugbank":["DB00780"],"chEBI":["8060"]},"childChemblIds":["CHEMBL1200895"],"linkedTargets":{"rows":["ENSG00000189221","ENSG00000069535"],"count":2},"linkedDiseases":{"rows":["EFO_0000673","MONDO_0007254","EFO_0003761"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and is indicated for unipolar depression and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL109822","canonicalSmiles":"CCCCn1c(Cc2ccc3c(c2)OCO3)nc2c(N)nc(F)nc21","inchiKey":"ARWHTQLGMWHTAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL109822","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04254"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL11306","canonicalSmiles":"CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(=O)NO)CC(C)C","inchiKey":"MOPRTFSMCQNUCT-CABCVRRESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL11306","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08403"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1138","canonicalSmiles":"O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1","inchiKey":"OLNTVTPDXPETLC-XPWALMASSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EZETIMIBE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ezetimibe","Ezetrol","Zetia"],"synonyms":["Ezetimibe","MK0653","NSC-758923","SCH-58235","SCH58235"],"crossReferences":{"DailyMed":["ezetimibe"],"PubChem":["144204996","170465013","26719841"],"Wikipedia":["Ezetimibe"],"drugbank":["DB00973"],"chEBI":["49040"]},"linkedTargets":{"rows":["ENSG00000015520"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003095","Orphanet_68367","EFO_0003762","EFO_0000266","EFO_1001461","EFO_0007304","EFO_0003914","EFO_0004211","EFO_0000712","Orphanet_391665","EFO_0003047","EFO_0000400","HP_0003124","HP_0001919","EFO_0001645","EFO_0000319","EFO_0004911","MONDO_0008315","Orphanet_309005","EFO_0000537","EFO_0000195","EFO_0000589","EFO_0004220","MONDO_0021187","EFO_0000764","EFO_0000612","MONDO_0005148","EFO_0005672","EFO_0004265"],"count":30},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 5 approved and 16 investigational indications."}
{"id":"CHEMBL1160593","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)cc1Br","inchiKey":"LHLHVDBXXZVYJT-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1160593","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01903"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1161632","canonicalSmiles":"O=C(O)O","inchiKey":"BVKZGUZCCUSVTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BICARBONATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bicarbonate","Bicarbonate Ion","Carbonic Acid Anion","Hydrogen Carbonate"],"crossReferences":{"Wikipedia":["Carbonic_acid"],"chEBI":["28976"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1163065","canonicalSmiles":"C[C@H](N)C(=O)NS(=O)(=O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"CWWYMWDIYBJVLP-YTMOPEAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALASA","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AlaSA"],"crossReferences":{"drugbank":["DB03376"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1171829","canonicalSmiles":"C[C@H](Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2ncc(C(F)(F)F)cc2F)CC1)C(F)(F)F","inchiKey":"YUUGYIUSCYNSQR-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BITOPERTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bitopertin","Paliflutine","R-1678","RG-1678","RO-4917838","RO-4917939","RO4917838"],"crossReferences":{"drugbank":["DB12426"]},"linkedTargets":{"rows":["ENSG00000196517"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","Orphanet_848","EFO_0004242"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1189679","canonicalSmiles":"O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2","inchiKey":"CPZBLNMUGSZIPR-NVXWUHKLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALONOSETRON","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["(-)-palonosetron","Aurothioglucose","NSC-743769","Palonosetron","Palonosetron, (3as, 3s)-"],"crossReferences":{"DailyMed":["palonosetron%20hydrochloride"],"Wikipedia":["Palonosetron"],"drugbank":["DB00377"],"chEBI":["85161"]},"childChemblIds":["CHEMBL1720"],"linkedTargets":{"rows":["ENSG00000166736"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","HP_0000486","EFO_0006911","MONDO_0100342","EFO_0000756","EFO_0003843","EFO_0000311","HP_0002018","EFO_0000565","MONDO_0001056","HP_0002017","MONDO_0001657","EFO_0004888","EFO_0000574","HP_0002013","EFO_0001378"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 6 approved and 12 investigational indications."}
{"id":"CHEMBL1200347","canonicalSmiles":"CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C.[I-]","inchiKey":"BFSMWENDZZIWPW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOPROPAMIDE IODIDE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201232","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Darbid"],"synonyms":["Dipramid","Dipramide","Isamid","Isopropamide (as iodide)","Isopropamide iodide","Isoproponum iodide","Marygin-m","NSC-15521","Piaccamide","Priamide","Priazimide","SKF-4740","Sanulcin","Tyrimide"],"crossReferences":{"PubChem":["11532965","56424103"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957."}
{"id":"CHEMBL1200750","canonicalSmiles":"CC(CN1c2ccccc2Sc2ccccc21)N(C)C.Cl","inchiKey":"XXPDBLUZJRXNNZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROMETHAZINE HYDROCHLORIDE","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL643","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mymethazine fortis","Phenergan","Phenergan nightime","Phenhalal","Phensedyl","Prometh fortis","Prometh plain","Promethacon","Promethazine","Promethazine hydrochloride","Promethazine hydrochloride plain","Promethazine plain","Promethegan","Q-mazine","Remsed","Sarantihist","Sominex","Zipan-25","Zipan-50"],"synonyms":["Promethazine hydrochloride"],"crossReferences":{"DailyMed":["promethazine%20hydrochloride"],"PubChem":["144209462","144213195","26747605","26747606","26752305","50106751","50106752","50106753","56422196","567521","855711"],"chEBI":["8462"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["MONDO_0100431","EFO_0006928","EFO_0005531","HP_0002017","MONDO_0005271","EFO_0007141","EFO_0000274","EFO_0004698","EFO_1000971","EFO_0003843","EFO_0003956","MONDO_0005475"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1951 and has 7 approved and 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200821","canonicalSmiles":"CCCOC(=O)Cn1cc(I)c(=O)c(I)c1","inchiKey":"ROSXARVHJNYYDO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPYLIODONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dionosil","Dionosil aqueous","Dionosil oily"],"synonyms":["A. G. 33-107","NSC-97103","Propyliodone","Propyliodonum"],"crossReferences":{"Wikipedia":["Propyliodone"],"drugbank":["DB09366"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1201548","drugType":"Unknown","blackBoxWarning":false,"name":"TYLOXAPOL","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alevaire","Superinone"],"synonyms":["NSC-90255","Tyloxapol"],"crossReferences":{"DrugCentral":["4738"],"Wikipedia":["Tyloxapol"]},"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 1990."}
{"id":"CHEMBL1205452","canonicalSmiles":"O=C(O)c1ccc2cc(C(=O)O)ccc2c1","inchiKey":"RXOHFPCZGPKIRD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1205452","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208320"],"drugbank":["DB08262"],"chEBI":["44460"]},"childChemblIds":["CHEMBL99236"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1208","canonicalSmiles":"CCn1nc(C(=O)O)c(=O)c2cc3c(cc21)OCO3","inchiKey":"VDUWPHTZYNWKRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINOXACIN","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cinobac","Cinoxacin"],"synonyms":["64716","Cinoxacin","NSC-304467"],"crossReferences":{"PubChem":["11110995","11110996","144203672","170465414","50104192","50104193","56422419","85230984","855948","90341598"],"Wikipedia":["Cinoxacin"],"drugbank":["DB00827"],"chEBI":["3716"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL1208309","canonicalSmiles":"CCCCCCCCCCCCCCCCS(=O)(=O)O","inchiKey":"SSILHZFTFWOUJR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1208309","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02776"],"chEBI":["43043"]},"childChemblIds":["CHEMBL549811"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1213633","canonicalSmiles":"CON","inchiKey":"GMPKIPWJBDOURN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHOXYAMINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methoxyamine"],"crossReferences":{"drugbank":["DB06328"]},"childChemblIds":["CHEMBL1609430"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1215331","canonicalSmiles":"N#Cc1ccc(N2N=C3c4ccc(C(=O)O)cc4CC[C@@H]3[C@@H]2C2CCCC2)cc1Cl","inchiKey":"XNULRSOGWPFPBL-REWPJTCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-3882845","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-3882845"],"crossReferences":{"drugbank":["DB11814"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230227","canonicalSmiles":"C[C@@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3C[C@](O)(C(=O)CO)Cc4c(O)c5c(c(O)c43)C(=O)c3ccccc3C5=O)O[C@H]2C)C[C@H](N)[C@@H]1O","inchiKey":"VQHRZZISQVWPLK-UIRGBLDSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SABARUBICIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sabarubicin"],"crossReferences":{"drugbank":["DB12410"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1232501","canonicalSmiles":"N[C@@H](Cc1cccc(O)c1)C(=O)O","inchiKey":"JZKXXXDKRQWDET-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232501","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03552"],"chEBI":["44303"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234848","canonicalSmiles":"O=C(O)CN(CC(=O)O)CC(=O)O","inchiKey":"MGFYIUFZLHCRTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITRILOTRIACETIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144209393","144210476","17389804","26752915","8139938"],"drugbank":["DB03040"],"chEBI":["44557"]},"childChemblIds":["CHEMBL1905907"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237055","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@H]3[C@H]1C5.Cl","inchiKey":"XHILEZUETWRSHC-NRGUFEMZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"HYDROMORPHONE HYDROCHLORIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL398707","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dilaudid","Dilaudid-hp","Exalgo","Hydromorphone hydrochloride","Palladone","Palladone-sr"],"synonyms":["Dihydromorphinone hydrochloride","Hydromorphone HCl","Hydromorphone hcl","Hydromorphone hydrochloride","Hydromorphone hydrochloride cii","NSC-117862"],"crossReferences":{"DailyMed":["hydromorphone%20hydrochloride"],"chEBI":["5791"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003890","HP_0012532","Orphanet_232","EFO_1000786","EFO_0001421","EFO_0004616","HP_0003419","HP_0003418","EFO_0003843","EFO_0000311"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for pain and drug dependence and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1256786","canonicalSmiles":"COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1","inchiKey":"BPZSYCZIITTYBL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FORMOTEROL","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Foradil","Formoterol"],"crossReferences":{"DailyMed":["formoterol%20fumarate","formoterol%20fumarate%20dihydrate"],"PubChem":["50125837"],"drugbank":["DB00983"],"chEBI":["63082"]},"childChemblIds":["CHEMBL2133469","CHEMBL1893395","CHEMBL3989798"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0007183","EFO_0000464","EFO_0009661","MONDO_0005271","EFO_0003768","EFO_1000637","HP_0002110","HP_0006536","MONDO_0100096","EFO_0000684","MONDO_0008903","EFO_0006505","MONDO_0004975","MONDO_0004979","EFO_0000341","HP_0025428"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 6 approved and 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1257015","canonicalSmiles":"COc1ccc(C(=O)NCc2cccnc2)cc1C(=O)NCc1cccnc1","inchiKey":"KYWCWBXGRWWINE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PICOTAMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["G-137","NSC-304384","Picotamide"],"crossReferences":{"PubChem":["11111675","50106897","85231198","90341089"],"drugbank":["DB13327"]},"childChemblIds":["CHEMBL1317747"],"linkedTargets":{"rows":["ENSG00000059377","ENSG00000006638"],"count":2},"linkedDiseases":{"rows":["HP_0004419"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for recurrent thrombophlebitis."}
{"id":"CHEMBL1259","canonicalSmiles":"COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)[C@H]3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1[C@@H](C2)[N+](C)(C)CC3","inchiKey":"JFXBEKISTKFVAB-AJQTZOPKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METOCURINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dimethyl tubocurarine","Dimethyltubocurarine","Dimethyltubocurarinium","Metocurine","Metocurine cation","Metocurine ion"],"crossReferences":{"Wikipedia":["Metocurine"],"drugbank":["DB01336"],"chEBI":["6900"]},"childChemblIds":["CHEMBL1739","CHEMBL2105841"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL127907","canonicalSmiles":"COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC","inchiKey":"BNDYIYYKEIXHNK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"WHI-P180","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["WHI-P180"],"crossReferences":{"drugbank":["DB03365"]},"childChemblIds":["CHEMBL1641775"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL129482","canonicalSmiles":"Oc1cc(O)c2c(c1)O[C@@H](c1ccc(O)c(O)c1)[C@@H](O)C2","inchiKey":"PFTAWBLQPZVEMU-ZFWWWQNUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(+)-EPICATECHIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(+)-epicatechin","Epicatechin"],"crossReferences":{"chEBI":["76125"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL134561","canonicalSmiles":"COc1cc(Cc2cnc(N)nc2N)c2c(c1OC)OC(C1CC1)C=C2","inchiKey":"HWJPWWYTGBZDEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ICLAPRIM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-100","Iclaprim","RO 48-2622","RO-48-2622","Ro-482622"],"crossReferences":{"Wikipedia":["Iclaprim"],"drugbank":["DB06358"]},"childChemblIds":["CHEMBL2105645"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1370446","canonicalSmiles":"Cc1sc2ccccc2c1CC1=NCCN1","inchiKey":"NDNKHWUXXOFHTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METIZOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metizoline"],"crossReferences":{"PubChem":["11110847","90341028"],"drugbank":["DB13614"]},"childChemblIds":["CHEMBL2106879","CHEMBL1605189"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL14130","canonicalSmiles":"O=[N+]([O-])c1ccc(O)cc1","inchiKey":"BTJIUGUIPKRLHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"P-NITROPHENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SR-1C2"],"crossReferences":{"PubChem":["144209642","144210437"],"Wikipedia":["4-Nitrophenol"],"drugbank":["DB04417"],"chEBI":["16836"]},"childChemblIds":["CHEMBL3183771"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1441","canonicalSmiles":"CCc1cc(C(N)=S)ccn1","inchiKey":"AEOCXXJPGCBFJA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHIONAMIDE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Trecator","Trecator-sc"],"synonyms":["1314 TH","1314-TH","BAYER 5312","Ethionamide","Ethionamidum","NSC-255115","Nizotin"],"crossReferences":{"DailyMed":["ethionamide"],"PubChem":["104171307","11112402","11532957","144209607","144213086","170465169","17389895","26752898","56422118","85148756"],"TG-GATEs":["135"],"Wikipedia":["Ethionamide"],"drugbank":["DB00609"],"chEBI":["4885"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and is indicated for tuberculosis and has 2 investigational indications."}
{"id":"CHEMBL1511","canonicalSmiles":"CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C","inchiKey":"RSEPBGGWRJCQGY-RBRWEJTLSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ESTRADIOL VALERATE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Climaval","Delestrogen","Estradiol valerate","Femtab","Progynon depot","Progynon-depot-10","Progynova"],"synonyms":[".beta.-estradiol 17-valerate","Estradiol 17-valerate","Estradiol Valerate","Estradiol valerate","NSC-17590","Oestradiol valerate"],"crossReferences":{"DailyMed":["estradiol%20valerate"],"PubChem":["144204865","56422428","855707"],"drugbank":["DB13956"],"chEBI":["31561"]},"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["EFO_0004248","Orphanet_64739","EFO_0000545","EFO_0008560","HP_0000132","MONDO_0002775","EFO_0003882","EFO_0000660","EFO_1001271","MONDO_0002146","EFO_0004266","HP_0008209","HP_0100607","EFO_1000096","HP_0100608","EFO_0003922"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 6 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1743014","drugType":"Antibody","blackBoxWarning":false,"name":"ETARACIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Abegrin","Abegrin vitaxin"],"synonyms":["ETARATUZUMAB","Etaracizumab","HLM60","MEDI-522","Vitaxin"],"linkedTargets":{"rows":["ENSG00000259207","ENSG00000138448"],"count":2},"linkedDiseases":{"rows":["EFO_0000685","EFO_0000756","EFO_0000681","EFO_0000676","MONDO_0008315","EFO_0002617","EFO_1001951","EFO_0000311"],"count":8},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL1743066","drugType":"Antibody","blackBoxWarning":false,"name":"RONTALIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RG-7415","RHUMAB IFNALPHA","RHUMAB-IFNALPHA","Rontalizumab"],"linkedTargets":{"rows":["ENSG00000228083","ENSG00000233816","ENSG00000197919","ENSG00000137080","ENSG00000214042","ENSG00000120242","ENSG00000236637","ENSG00000234829","ENSG00000186803","ENSG00000120235","ENSG00000188379","ENSG00000147873","ENSG00000147885"],"count":13},"linkedDiseases":{"rows":["EFO_0002690"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1852492","canonicalSmiles":"COc1cc(C(=O)c2c(C)oc3c(OP(=O)(O)O)c(OC)ccc23)cc(OC)c1OC","inchiKey":"MYDHDVLPMRNDAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1852492","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06313"]},"childChemblIds":["CHEMBL1823160"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908336","canonicalSmiles":"CCOC(=O)[C@@H]1CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@H]1OC","inchiKey":"NGNBWGMTPDSDCJ-QDFUUMMMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIDECAMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aboren","Espinomycin a","Leucomycin v, 3,4b-dipropanoate","Macropen","Medecamycin a1","Medemycin","Medemycin a1","Midecamycin","Midecamycin a1","Midecin","Momicine","Mydecamycin","Mydecamycin a1","Myoxam","NSC-154011","Normicina","Platenomycin b1","Rubimycin","SF-837","SF-837A1","Turimycin p3","YL-704B1"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL195560","canonicalSmiles":"Oc1ccc(C2=COc3cc(O)ccc3C2)cc1","inchiKey":"QCNUDDPWPNUALZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOPHENOXODIOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isophenoxodiol"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2030402","canonicalSmiles":"O=c1[nH]c([C@@H]2CCCN2)nc2c1oc1ccc(Cl)cc12","inchiKey":"JJWLXRKVUJDJKG-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2030402","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12357"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2040682","canonicalSmiles":"CC(C)C(=O)OCC(=O)[C@@]12O[C@H](C3CCCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C","inchiKey":"LUKZNWIVRBCLON-GXOBDPJESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CICLESONIDE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alvesco","Alvesco 160","Alvesco 80","Omnaris","Zetonna"],"synonyms":["BI54903","Ciclesonide","RPR-251526","RPR251526"],"crossReferences":{"DailyMed":["ciclesonide"],"PubChem":["144206039"],"drugbank":["DB01410"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","HP_0006536","MONDO_0100096","EFO_0000684","EFO_1000024","MONDO_0005271","MONDO_0004979","EFO_0000341","EFO_1001417","HP_0001742","EFO_0003956"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 6 approved and 4 investigational indications."}
{"id":"CHEMBL2103773","canonicalSmiles":"CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1.[Br-]","inchiKey":"VWZPIJGXYWHBOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OTILONIUM BROMIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1433361","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Doralin","Octylonium bromide","Otilonium bromide","SP-63","SP63","Spasmoctyl 40"],"crossReferences":{"PubChem":["144205612","170466098"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2103832","canonicalSmiles":"CN1CCN(c2cccc3[nH]c(=O)oc23)CC1","inchiKey":"YVPUUUDAZYFFQT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARDOPRUNOX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DU 126891","DU-126891","Pardoprunox","SLV 308","SLV-308","SLV308"],"crossReferences":{"drugbank":["DB12061"]},"childChemblIds":["CHEMBL2105649"],"linkedTargets":{"rows":["ENSG00000178394","ENSG00000149295","ENSG00000151577"],"count":3},"linkedDiseases":{"rows":["MONDO_0005180"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2103842","canonicalSmiles":"C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1","inchiKey":"UWXSAYUXVSFDBQ-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VARLITINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-00334543","ARRY-334543","ARRY-543","ASLAN-001","ASLAN001","Varlitinib"],"crossReferences":{"drugbank":["DB05944"]},"childChemblIds":["CHEMBL2105679"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000141736"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0003060","MONDO_0001056","EFO_0002618","EFO_0000182","MONDO_0007254","EFO_0005221","EFO_0000311"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL2104149","canonicalSmiles":"CCC(=O)n1c(=O)n(C2CCN(CCC(C#N)(c3ccccc3)c3ccccc3)CC2)c2ccccc21","inchiKey":"FLKWNFFCSSJANB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEZITRAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bezitramide","Burgodin","IDS-NB-007","N02AC05","R 4845","R-4845"],"crossReferences":{"drugbank":["DB01459"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104489","canonicalSmiles":"CC(=O)O[C@]1(C(C)=O)CCC2[C@@H]3C[C@H](C)C4=CCCC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"KDLNOQQQEBKBQM-HDFGVWRLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANAGESTONE ACETATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Carcinogenicity"],"year":1969},"tradeNames":["Anatropin"],"synonyms":["Anagestone","Anagestone acetate","NSC-73880","ORF-1658"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Germany  in 1969 due to Carcinogenicity."}
{"id":"CHEMBL2105116","canonicalSmiles":"Nc1nc(=O)c2sc(=O)n([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2[nH]1","inchiKey":"TZYVRXZQAWPIAB-FCLHUMLKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISATORIBINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04860"]},"childChemblIds":["CHEMBL3989482"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105401","canonicalSmiles":"O=c1oc2ccccc2c(O)c1C(CC(O)c1ccc(Cl)cc1)c1ccc(Cl)s1","inchiKey":"WRGOVNKNTPWHLZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIOCLOMAROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tioclomarol"],"crossReferences":{"drugbank":["DB13451"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105643","canonicalSmiles":"COc1ccc(/C=C\\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O.NC(CO)(CO)CO","inchiKey":"FIDMEHCRMLKKPZ-YSMBQZINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSBRETABULIN TROMETHAMINE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1206232","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Zybrestat"],"synonyms":["Fosbretabulin tromethamine"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000137267","ENSG00000167552","ENSG00000101162","ENSG00000123416","ENSG00000137285","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["EFO_1001901","MONDO_0008170"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107319","canonicalSmiles":"Cl.N[C@@H](CCC(=O)N[C@@H](CS(=O)(=O)CCOP(=O)(N(CCCl)CCCl)N(CCCl)CCCl)C(=O)N[C@@H](C(=O)O)c1ccccc1)C(=O)O","inchiKey":"NECZZOFFLFZNHL-XVGZVFJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANFOSFAMIDE HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2111086","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Telcyta"],"synonyms":["Canfosfamide hcl","Canfosfamide hydrochloride","Canfosfamidhydrochloride","TER-286","TER286","TLK-286","TLK286"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2107366","canonicalSmiles":"Cc1cccc([C@H](C)c2c[nH]c(=S)[nH]2)c1C","inchiKey":"WQXVKEDUCPMRRI-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REZATOMIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGN-203818","Agn 203818","Agn 203818 free base","Rezatomidine"],"crossReferences":{"drugbank":["DB12143"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2108031","drugType":"Cell","blackBoxWarning":false,"name":"GALGENPROSTUCEL-L","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Gvax prostate"],"synonyms":["CG-1940","CG1940","Galgenprostucel-l"],"description":"Cell drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109225","drugType":"Unknown","blackBoxWarning":false,"name":"RUBELLA VIRUS VACCINE LIVE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Meruvax"],"synonyms":["Rubella virus vaccine live"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109253","drugType":"Antibody","blackBoxWarning":false,"name":"HOKT3","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HOKT3","Hokt3"],"linkedTargets":{"rows":["ENSG00000198851"],"count":1},"linkedDiseases":{"rows":["MONDO_0005147","EFO_0003778"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109416","drugType":"Antibody","blackBoxWarning":false,"name":"MORAB-028","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MORAB-028","Morab-028"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109460","drugType":"Antibody","blackBoxWarning":false,"name":"SCH-708980","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SCH-708980","Sch-708980"],"linkedTargets":{"rows":["ENSG00000136634"],"count":1},"linkedDiseases":{"rows":["EFO_0005044"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109470","drugType":"Antibody","blackBoxWarning":false,"name":"PERAKIZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Perakizumab","RG-4934","RG4934","RO-5310074","RO5310074"],"linkedTargets":{"rows":["ENSG00000112115"],"count":1},"linkedDiseases":{"rows":["EFO_0003778"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109572","drugType":"Antibody","blackBoxWarning":false,"name":"ANTI-SCLEROSTIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANTI-SCLEROSTIN"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109679","drugType":"Antibody","blackBoxWarning":false,"name":"IDEC-159 111IN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IDEC-159","Idec-159 (111in)","Idec-159 111in"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110784","canonicalSmiles":"CCOC(=O)CN1CCN(C(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)CC1","inchiKey":"XDUOTWNXVDBCDY-VOTSOKGWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINEPAZET","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cinepazet"],"crossReferences":{"drugbank":["DB13342"]},"childChemblIds":["CHEMBL2106028"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2133806","canonicalSmiles":"Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1","inchiKey":"JRWCBEOAFGHNNU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-38877605","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-38877605","Jnj-38877605"],"crossReferences":{"PubChem":["137276033"],"drugbank":["DB13113"]},"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2146133","canonicalSmiles":"COc1ccc2[n-]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.COc1ccc2[n-]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.[Mg+2]","inchiKey":"KWORUUGOSLYAGD-YPPDDXJESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESOMEPRAZOLE MAGNESIUM","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201320","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Esomeprazole magnesium","Nexium","Nexium 24hr"],"synonyms":["Esomeprazole (as magnesium)","Esomeprazole magnesium","Esomeprazole magnesium hydrate","Esomeprazole magnesium trihydrate","H199/18 MAGNESIUM TRIHYDRATE"],"crossReferences":{"DailyMed":["esomeprazole%20magnesium"],"chEBI":["50309"]},"linkedTargets":{"rows":["ENSG00000105675"],"count":1},"linkedDiseases":{"rows":["EFO_0000280","EFO_0000685","EFO_0003898","EFO_0004607","EFO_0007549","EFO_0008533","EFO_0003948","EFO_0009454","MONDO_0004247","EFO_1000961","EFO_0000342","MONDO_0005148","MONDO_0005178","HP_0100633"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 8 approved and 4 investigational indications."}
{"id":"CHEMBL2178100","canonicalSmiles":"CN1C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)[C@@]1(CO)c1ccccc1","inchiKey":"VAJGULUVTFDTAS-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2178100","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12461"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2218892","canonicalSmiles":"C/C(=N\\O)C(C)NCC(C)(C)CNC(C)/C(C)=N/O","inchiKey":"BPNZYADGDZPRTK-MAEUFBSDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EXAMETAZIME","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DL HM-PAO","DL-HM-PAO","Exametazime","Hexametazine"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2221250","canonicalSmiles":"C[C@@H]1NC(=O)[C@@H](N)CNC(=O)[C@H](C2CCNC(=N)N2)NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)CC(N)CCCN)NC1=O.N=C1NCCC([C@@H]2NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)CC(N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC2=O)N1","inchiKey":"VCOPTHOUUNAYKQ-DAOVIKHBSA-N","drugType":"Protein","blackBoxWarning":true,"name":"CAPREOMYCIN","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Capastat"],"synonyms":["Capostatin","Capreomicin","Capreomycin","Capromycin"],"crossReferences":{"DailyMed":["capreomycin%20sulfate"],"DrugCentral":["3063"]},"childChemblIds":["CHEMBL2218913"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and is indicated for tuberculosis and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL223873","canonicalSmiles":"Cc1cccc(C)c1Nc1ncc(-c2ccccc2)n2cncc12","inchiKey":"KKYYLKPGILUPOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL223873","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08056"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2263632","canonicalSmiles":"COc1cccc(-c2cc(F)c(Nc3ncccc3C(=O)O)c(F)c2)c1","inchiKey":"OMPATGZMNFWVOH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASLAN-003","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASLAN-003","ASLAN003","Aslan-003","Aslan003","Farudodstat"],"linkedTargets":{"rows":["ENSG00000102967"],"count":1},"linkedDiseases":{"rows":["EFO_0000222"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL237786","canonicalSmiles":"COc1ccc(-c2cc(N3C[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ncn2)cn1","inchiKey":"IFKWHPAWYJARQJ-DYVFJYSZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL237786","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08445"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2387742","canonicalSmiles":"C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCC)cc1O","inchiKey":"REOZWEGFPHTFEI-JKSUJKDBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANNABIDIVARIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CBD-V","CBDV","Cannabidivarin","Cannabidivarol","GWP42006","Gwp-42006"],"crossReferences":{"drugbank":["DB14050"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL258918","canonicalSmiles":"C[C@H]1CC(=O)C[C@@H]2CC[C@H]3[C@@H]4CC[C@H](O)[C@@]4(C)CC[C@@H]3[C@@]12C","inchiKey":"UXYRZJKIQKRJCF-TZPFWLJSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MESTEROLONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pro-viron"],"synonyms":["Androviron","Mesterolone","NSC-75054","Proviron","SH 723","SH-723","Testiwop"],"crossReferences":{"Wikipedia":["Mesterolone"],"drugbank":["DB13587"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL274064","canonicalSmiles":"Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1","inchiKey":"VSPFURGQAYMVAN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SB-220025","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SB-220025"],"crossReferences":{"PubChem":["103905253","124349771","124349772","29217658"],"drugbank":["DB04338"],"chEBI":["82713"]},"childChemblIds":["CHEMBL1909407"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL282837","canonicalSmiles":"O=C(Cn1c(Cl)cnc(NCC(F)(F)c2cccc[n+]2[O-])c1=O)NCc1ccccc1F","inchiKey":"ZIGSBBKEPNQXRG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL282837","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07550"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL303950","canonicalSmiles":"O=C1OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccc([N+](=O)[O-])c3cccc1c23","inchiKey":"FLWABCQDXUKNQY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL303950","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08204"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039582","canonicalSmiles":"CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(N)=O)C(C)C","inchiKey":"OWMZNFCDEHGFEP-NFBCVYDUSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SECRETIN","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Secretin-ferring","Secretin-kabi"],"synonyms":["Secretin","Secretin (human, porcine, etc.)","Secretin, unspecified"],"linkedTargets":{"rows":["ENSG00000080293"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0000278","EFO_0003758","EFO_0000342","EFO_0001073","EFO_0008533"],"count":6},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 6 investigational indications."}
{"id":"CHEMBL3185133","canonicalSmiles":"C=CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"ATXHVCQZZJYMCF-XUDSTZEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3185133","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205271"],"drugbank":["DB01431"],"chEBI":["31189"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3188993","canonicalSmiles":"O=C(O)/C=C/C(=O)O.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1","inchiKey":"ZTHJULTYCAQOIJ-WXXKFALUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"QUETIAPINE FUMARATE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL716","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Quetiapine fumarate","Seroquel","Seroquel xr"],"synonyms":["FK-947E","FK947E","ICI 204,636","ICI-204636","Quetiapine (as fumarate)","Quetiapine fumarate","Quetiapine hemifumarate","Utapine","ZD-5077","ZD5077","ZM 204,636","ZM-204636"],"crossReferences":{"DailyMed":["quetiapine%20fumarate"],"PubChem":["144212683"],"chEBI":["8708"]},"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0002009","HP_0012076","HP_0000726","EFO_0009963","EFO_0005407","EFO_0001358","EFO_1001917","HP_0000713","MONDO_0002046","EFO_1001892","EFO_0000289","MONDO_0002050","Orphanet_79292","MONDO_0005301","EFO_0004257","EFO_0003761","MONDO_0007079","EFO_0004242","EFO_0005230","EFO_0005411","EFO_0009964"],"count":22},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 6 approved and 16 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL32838","canonicalSmiles":"CO[C@H]1[C@H]([C@@]2(C)O[C@@H]2CC=C(C)C)[C@]2(CC[C@H]1OC(=O)/C=C/C=C/C=C/C=C/C(=O)O)CO2","inchiKey":"NGGMYCMLYOUNGM-CSDLUJIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FUMAGILLIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Fumidil"],"synonyms":["(-)-fumagillin","Amebacilin","Fumagillin","NSC-9168","ZGN-201"],"crossReferences":{"PubChem":["144205619","144212727","26757080"],"drugbank":["DB02640"],"chEBI":["48635"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3286797","canonicalSmiles":"COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1","inchiKey":"LWJGMYMNSNVCEM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04418948","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-04418948"],"crossReferences":{"drugbank":["DB12024"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301588","drugType":"Antibody","blackBoxWarning":false,"name":"TAREXTUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OMP-59R5","Tarextumab"],"linkedTargets":{"rows":["ENSG00000074181","ENSG00000134250"],"count":2},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","EFO_0000702"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL353972","canonicalSmiles":"CCC1(c2cnc[nH]2)Cc2ccccc2C1","inchiKey":"HSWPZIDYAHLZDD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATIPAMEZOLE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Antisedan"],"synonyms":["4-(2-ethyl-2-indanyl)imidazole.","Atipamezole","MPV-1248"],"crossReferences":{"PubChem":["144206556","170466187"],"Wikipedia":["Atipamezole"],"drugbank":["DB11481"]},"childChemblIds":["CHEMBL2361649"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544923","drugType":"Antibody","blackBoxWarning":false,"name":"LABETUZUMAB GOVITECAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-ceacam5-sn 38","IMMU-130","Labetuzumab govitecan"],"linkedTargets":{"rows":["ENSG00000105388"],"count":1},"linkedDiseases":{"rows":["EFO_1001480","EFO_1000657","MONDO_0021063"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545034","drugType":"Small molecule","blackBoxWarning":false,"name":"ONO-2333MS","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ono-2333ms"],"linkedTargets":{"rows":["ENSG00000120088"],"count":1},"linkedDiseases":{"rows":["MONDO_0002009"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545040","canonicalSmiles":"CC(C)(C)OC(=O)NCCN1CC2CN(C[C@H](O)COc3ccc(C#N)cc3)CC(C1)O2","inchiKey":"JRHUUZPSMQIWBQ-PELRDEGISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD7009","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd7009"],"linkedTargets":{"rows":["ENSG00000183873","ENSG00000055118"],"count":2},"linkedDiseases":{"rows":["EFO_0000275"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545162","drugType":"Small molecule","blackBoxWarning":false,"name":"PBF-680","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pbf-680"],"linkedTargets":{"rows":["ENSG00000163485"],"count":1},"linkedDiseases":{"rows":["MONDO_0004979","EFO_0000341"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545228","drugType":"Small molecule","blackBoxWarning":false,"name":"JTS-653","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jts-653"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545432","canonicalSmiles":"CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B1OC(=O)C(CC(=O)O)(CC(=O)O)O1","inchiKey":"MBOMYENWWXQSNW-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IXAZOMIB CITRATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ninlaro"],"synonyms":["Ixazomib citrate","MLN-9708","MLN9708"],"crossReferences":{"DailyMed":["ixazomib%20citrate"]},"linkedTargets":{"rows":["ENSG00000100804"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","MONDO_0013730","EFO_0000616","MONDO_0000873","EFO_0000558","EFO_0000220","EFO_1000314","MONDO_0007254","EFO_0000222","EFO_1001469","Orphanet_85443","EFO_0006738","EFO_0000311","EFO_0006475","EFO_0000574","EFO_0006544","EFO_0001378","MONDO_0020743","EFO_0000519"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 3 approved and 13 investigational indications."}
{"id":"CHEMBL356388","canonicalSmiles":"CCOC(=O)c1cnc2c(cnn2CC)c1NN=C(C)C","inchiKey":"OPQRBXUBWHDHPQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETAZOLATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EHT-0202","Etazolate","SQ-20009"],"crossReferences":{"PubChem":["11111137","11113501","124880016","90341463"],"Wikipedia":["Etazolate"]},"childChemblIds":["CHEMBL1256671"],"linkedTargets":{"rows":["ENSG00000166206"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL36","canonicalSmiles":"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1","inchiKey":"WKSAUQYGYAYLPV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRIMETHAMINE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chloridin","Daraprim","Malacide"],"synonyms":["Chloridine","GNF-PF-5586","NSC-3061","Pyrimethamine","Pyrimethaminum","RP-4753","TCMDC-123831","TCMDC-125860","WR-2978"],"crossReferences":{"DailyMed":["pyrimethamine"],"PubChem":["104171273","11112140","124881960","124881963","124881964","144203883","144209032","144210449","162163291","170464930","17389746","174006175","26747011","26747012","26751532","50100376","50104113","56422411","69611","855854"],"Wikipedia":["Pyrimethamine"],"drugbank":["DB00205"],"chEBI":["8673"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and is indicated for toxoplasmosis and malaria and has 19 investigational indications."}
{"id":"CHEMBL360356","canonicalSmiles":"NS(=O)(=O)c1nnc(-c2ccccc2Cl)s1","inchiKey":"PZVGOWIIHCUHAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL360356","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07632"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3822503","canonicalSmiles":"C[N+](C)(C)CCCOc1ccc(-c2c3nc(cc4ccc([nH]4)c(-c4ccc(OCCC[N+](C)(C)C)cc4)c4nc(cc5ccc2[nH]5)C=C4)C=C3)cc1.[Cl-].[Cl-]","inchiKey":"KJLHJQGDBJNMPU-XRFOENPRSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"EXEPORFINIUM CHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3824393","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Exeporfinium chloride","Xf-73"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3833338","canonicalSmiles":"CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](NC(=N)N)[C@H](O)[C@@H](NC(=N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O.CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](NC(=N)N)[C@H](O)[C@@H](NC(=N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O.O=S(=O)(O)O.O=S(=O)(O)O","inchiKey":"CPCMMVSHXFLUOU-HHVGSZDJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STREPTODUOCIN","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3833407","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Combistrep","Distrycin"],"synonyms":["Dihydrostreptomycin-streptomycin","Streptoduocin"],"crossReferences":{"DrugCentral":["4722"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3833401","canonicalSmiles":"Cl[Al](Cl)Cl","inchiKey":"VSCWAEJMTAWNJL-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"ALUMINUM CHLORIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Aluminium chloride","Aluminium chloride hexahydrate","Aluminum chloride","Aluminum chloride hexahydrate","NSC-143015","NSC-143016"],"crossReferences":{"drugbank":["DB11081"]},"childChemblIds":["CHEMBL3833314"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for acne and has 1 investigational indication."}
{"id":"CHEMBL383921","canonicalSmiles":"CCOc1ccccc1O[C@H](c1ccccc1)[C@H]1CNCCO1","inchiKey":"CBQGYUDMJHNJBX-RTBURBONSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL383921","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB00234"]},"childChemblIds":["CHEMBL2105282","CHEMBL1556230"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3905910","canonicalSmiles":"CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccc(C(F)(F)F)cc4Cl)oc23)[C@@H]1CO","inchiKey":"MRPGRAKIAJJGMM-OCCSQVGLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VORUCICLIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["P1446a-05","Voruciclib"],"crossReferences":{"drugbank":["DB15157"]},"linkedTargets":{"rows":["ENSG00000135446"],"count":1},"linkedDiseases":{"rows":["EFO_0000095","EFO_0000756","MONDO_0044881","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL393949","canonicalSmiles":"N[C@H](CCc1ccccc1)P(=O)(O)C[C@@H](Cc1ccccc1)C(=O)O","inchiKey":"QELOIXSGJMIHBZ-MSOLQXFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL393949","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07448"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL394875","canonicalSmiles":"CSC[C@H](N)C(=O)O","inchiKey":"IDIDJDIHTAOVLG-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL394875","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02216"],"chEBI":["45658"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL398615","canonicalSmiles":"CS(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(C(N)=O)CC1)c1ccccc1S2","inchiKey":"BQDBKDMTIJBJLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METOPIMAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EXP 999","EXP-999","Metopimazine"],"crossReferences":{"Wikipedia":["Metopimazine"],"drugbank":["DB13591"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989901","canonicalSmiles":"CC(CCCCCCCCCCCCc1ccc([123I])cc1)CC(=O)O","inchiKey":"NPCIWINHUDIWAV-NSYCNWAXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOFILTIC ACID I 123","maximumClinicalTrialPhase":2,"parentId":"CHEMBL336360","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Zemiva"],"synonyms":["123i-bmipp","BMIP-P I-123","BMIPP","BMIPP I-123","Iodofiltic acid (123i)","Iodofiltic acid i 123","Iodofiltic acid i-123"],"crossReferences":{"drugbank":["DB05683"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3989915","canonicalSmiles":"CC(C)C[C@@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](N)Cc1ccccc1)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(C(=O)O)CC1","inchiKey":"FWMNVWWHGCHHJJ-SKKKGAJSSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DIFELIKEFALIN","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Korsuva"],"synonyms":["4-PIPERIDINECARBOXYLIC ACID, N1-(D-PHENYLALANYL-D-PHENYLALANYL-D-LEUCYL-D-LYSYL)-4-AMINO-","CR-845","CR845","Cr-845 acetate","Difelikefalin","Difelikefalin acetate","FE-202845","FE202845","MR-13A9","MR13A9"],"crossReferences":{"drugbank":["DB11938"]},"linkedTargets":{"rows":["ENSG00000082556"],"count":1},"linkedDiseases":{"rows":["HP_0000989","EFO_0003884","EFO_0003843","MONDO_0005178"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for chronic kidney disease and pruritus and has 2 investigational indications."}
{"id":"CHEMBL3990011","drugType":"Antibody","blackBoxWarning":false,"name":"ROVALPITUZUMAB TESIRINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rovalpituzumab tesirine","SC-002","SC0002"],"linkedTargets":{"rows":["ENSG00000090932"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000702","EFO_0000311"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3990456","canonicalSmiles":"Cn1cc(-c2[nH]c3cc(NC(=O)[C@H](N)C4CCCCC4)cc4c3c2C=NNC4=O)cn1","inchiKey":"NDEXUOWTGYUVGA-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3990456","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12611"]},"childChemblIds":["CHEMBL4299711"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL403350","canonicalSmiles":"Clc1cccc(-c2cc(NCc3ccncc3)n3nccc3n2)c1Cl","inchiKey":"CVYWYUAQFJMLEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL403350","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08531"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL409153","canonicalSmiles":"C[C@@H](c1nc(-c2ccc(C#N)cc2)cs1)[C@](O)(Cn1cncn1)c1cc(F)ccc1F","inchiKey":"DDFOUSQFMYRUQK-RCDICMHDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISAVUCONAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cresemba"],"synonyms":["BAL-4815","Isavuconazole"],"crossReferences":{"Wikipedia":["Isavuconazole"],"drugbank":["DB11633"],"chEBI":["85979"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL41","canonicalSmiles":"CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1","inchiKey":"RTHCYVBBDHJXIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLUOXETINE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fluoxetin ratiopharm","Fluoxetine","Fluval","NSC-283480","NSC-758685","Prozac","Sarafem","Symbyax"],"crossReferences":{"DailyMed":["fluoxetine%20hydrochloride"],"PubChem":["104171153","144203695","170465374","26751973","26755310","50104648","90341619"],"Wikipedia":["Fluoxetine"],"drugbank":["DB00472"],"chEBI":["86990"]},"childChemblIds":["CHEMBL1201082"],"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0001361","EFO_0005687","EFO_0004262","EFO_0002610","MONDO_0002009","MONDO_0024290","HP_0000726","EFO_0005669","EFO_0003768","EFO_1001917","HP_0011868","EFO_0007191","EFO_0003948","HP_0100543","EFO_0000289","MONDO_0002050","EFO_0000474","MONDO_0021698","EFO_0000712","EFO_0003761","EFO_0009854","EFO_0004242","EFO_0005230","EFO_0008522","EFO_0004215","HP_0002140","HP_0012076","EFO_0000677","EFO_0003758","EFO_0009963","EFO_0005407","EFO_0001358","EFO_0001073","EFO_1001050","EFO_0000546","EFO_0008623","MONDO_0100096","MONDO_0005147"],"count":39},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 6 approved and 32 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL41286","canonicalSmiles":"CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O","inchiKey":"TYNLGDBUJLVSMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIACEREIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fisiodar"],"synonyms":["AC-201","Artrodar","Diacerein","Diacerhein","Diacetylrhein","Diora","M-01AX21","M01AX21","NSC-758147","Rhein diacetate","SF-277","Verboril","Zondar"],"crossReferences":{"PubChem":["104171387","144204407","170466475","26746957","855680"],"Wikipedia":["Diacerein"],"drugbank":["DB11994"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for rheumatic disease and has 10 investigational indications."}
{"id":"CHEMBL421615","canonicalSmiles":"O=C(O)c1cc(O)c2c(c1)Cc1cccc(O)c1C2=O","inchiKey":"OZFQHULMMDWMIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL421615","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["508365"],"drugbank":["DB13175"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297224","canonicalSmiles":"CN(C)CC1CCOC1(c1ccccc1)c1ccccc1","inchiKey":"BOTHKNZTGGXFEQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BLARCAMESINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Anavex"],"synonyms":["Anavex 2-73","Blarcamesine"],"crossReferences":{"drugbank":["DB05592"]},"childChemblIds":["CHEMBL4594269"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297289","canonicalSmiles":"CN1CCN(C(=O)[C@H](CCCN[C@@H]2C[C@H]2c2ccc(F)cc2)NC(=O)c2ccc(-n3ccnn3)cc2)CC1","inchiKey":"KQKBMHGOHXOHTD-KKUQBAQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMG-7289","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bomedemstat","Img-7289"],"crossReferences":{"drugbank":["DB15126"]},"linkedTargets":{"rows":["ENSG00000004487"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000702","EFO_0000222","EFO_0000479"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297402","canonicalSmiles":"Cc1nnnn1N=Cc1ccc(O)c(C(c2ccc(O)cc2)c2cc(C=Nn3nnnc3C)ccc2O)c1","inchiKey":"BLUJRJMLDHEMRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VP-14637","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mdt-637","Vp-14637"],"crossReferences":{"drugbank":["DB12195"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297451","canonicalSmiles":"CC[C@@H](C)Nc1cc(C(=O)N[C@@H]2C[C@@H]3CC[C@H](C2)N3c2ccc(C(=O)C3CC3)cn2)c(C)cc1C(N)=O","inchiKey":"LHGWWAFKVCIILM-HLRQEUIKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XL-888","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Exel-4888","Xl-888","Xl888"],"crossReferences":{"drugbank":["DB12981"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297542","canonicalSmiles":"CC(C)Oc1ncc(-c2nc(-c3cccc4c3ccn4CCCC(=O)O)no2)cc1Cl","inchiKey":"NFIGDBFIDKDNIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-2018682","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK2018682","Gsk-2018682","Gsk2018682"],"crossReferences":{"drugbank":["DB11987"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297590","canonicalSmiles":"COc1ccc(-n2nccn2)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1","inchiKey":"NBGABHGMJVIVBW-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DARIDOREXANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACT-541468","Act-541468","Daridorexant","Nemorexant"],"crossReferences":{"drugbank":["DB15031"]},"childChemblIds":["CHEMBL4650216"],"linkedTargets":{"rows":["ENSG00000137252","ENSG00000121764"],"count":2},"linkedDiseases":{"rows":["HP_0000083","EFO_0001421","EFO_0000341","EFO_0003918","EFO_0004698"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297744","drugType":"Unknown","blackBoxWarning":false,"name":"ELX-02","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ELX-02","Elx-02","Exaluren","NB-124"],"linkedTargets":{"rows":["ENSG00000148303","ENSG00000142937","ENSG00000171863","ENSG00000265681","ENSG00000116251","ENSG00000198755","ENSG00000147403","ENSG00000177954","ENSG00000142534","ENSG00000124614","ENSG00000100316","ENSG00000008988","ENSG00000149806","ENSG00000137154","ENSG00000161016","ENSG00000143947","ENSG00000167526","ENSG00000166441","ENSG00000089157","ENSG00000186468","ENSG00000130255","ENSG00000105372","ENSG00000172809","ENSG00000161970","ENSG00000171858","ENSG00000231500","ENSG00000164587","ENSG00000142676","ENSG00000145425","ENSG00000142541","ENSG00000071082","ENSG00000129824","ENSG00000122406","ENSG00000213741","ENSG00000108298","ENSG00000188846","ENSG00000136942","ENSG00000197958","ENSG00000105640","ENSG00000162244","ENSG00000170889","ENSG00000174444","ENSG00000174748","ENSG00000138326","ENSG00000110700","ENSG00000137818","ENSG00000083845","ENSG00000122026","ENSG00000131469","ENSG00000144713","ENSG00000198918","ENSG00000109475","ENSG00000168028","ENSG00000147604","ENSG00000145592","ENSG00000108107","ENSG00000198242","ENSG00000115268","ENSG00000114391","ENSG00000089009","ENSG00000063177","ENSG00000182774","ENSG00000198034","ENSG00000241343","ENSG00000182899","ENSG00000149273","ENSG00000163682","ENSG00000125691","ENSG00000233927","ENSG00000112306","ENSG00000134419","ENSG00000197756","ENSG00000118181","ENSG00000105193","ENSG00000140988","ENSG00000197728","ENSG00000229117","ENSG00000156482"],"count":78},"linkedDiseases":{"rows":["EFO_0000508","EFO_0003086","Orphanet_586","Orphanet_213"],"count":4},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297829","drugType":"Antibody","blackBoxWarning":false,"name":"SINTILIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Tyvyt"],"synonyms":["ANTI-PD-1 MONOCLONAL ANTIBODY IBI308","IBI-308","IBI308","Ibi308","Sintilimab"],"linkedTargets":{"rows":["ENSG00000188389"],"count":1},"linkedDiseases":{"rows":["MONDO_0009348","EFO_0000348","MONDO_0003060","EFO_0000365","EFO_1001972","EFO_1001901","MONDO_0021117","EFO_0000681","EFO_0002913","MONDO_0044887","MONDO_0007254","EFO_1000657","EFO_0000255","EFO_0004252","MONDO_0044704","EFO_1001951","MONDO_0001056","EFO_1001480","EFO_0000588","EFO_0003968","MONDO_0002974","MONDO_0008903","EFO_0000182","EFO_0000183","EFO_0000707","EFO_0001416","EFO_0000616","EFO_0005922","EFO_0000503","MONDO_0008170","EFO_0000349","EFO_0000403","MONDO_0004669","EFO_0000313","EFO_1001968","EFO_0003060","EFO_0000621","EFO_0005221","EFO_0000311","EFO_1001961","EFO_0000211","EFO_0005570","MONDO_0056806","MONDO_0003572","MONDO_0002120","MONDO_0019472","MONDO_0011962","EFO_0004142","EFO_0000574","EFO_0000702","EFO_0000199","MONDO_0003219","EFO_0000691","EFO_0000181"],"count":54},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 41 investigational indications."}
{"id":"CHEMBL4297876","drugType":"Antibody","blackBoxWarning":false,"name":"ZALIFRELIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGEN1884","Agen-1884","Agen1884","Zalifrelimab"],"linkedTargets":{"rows":["ENSG00000163599"],"count":1},"linkedDiseases":{"rows":["EFO_0000294","EFO_1000026","EFO_0003968","MONDO_0002974","EFO_0002517","EFO_1001968","EFO_0003060","EFO_0000311"],"count":8},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL4297955","drugType":"Unknown","blackBoxWarning":false,"name":"FOLLITROPIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rekovelle"],"synonyms":["FE-999049","Fe 999049","Follicle stimulating hormone","Follitropin","Follitropin alpha","Follitropin delta","Follitropin epsilon","Follitropin gamma","Gonal f"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL4298090","drugType":"Protein","blackBoxWarning":false,"name":"SIMLUKAFUSP ALFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FAP-IL-2V","FAP-IL2V FP RO6874281","FAP-IL2v","RG-7461","RG7461","RO-6874281","RO6874281","Ro-6874281","Ro6874281","Simlukafusp alfa"],"linkedTargets":{"rows":["ENSG00000078098","ENSG00000147168","ENSG00000100385"],"count":3},"linkedDiseases":{"rows":["EFO_1000044","EFO_0000681","EFO_0002617"],"count":3},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298150","canonicalSmiles":"CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CN1CC(C(=O)O)C1.CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CN1CC(C(=O)O)C1.O=C(O)/C=C/C(=O)O","inchiKey":"JNLIKIBISICTMS-PEJBKAKVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIPONIMOD FUMARATE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2336071","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mayzent"],"synonyms":["NVP-BAF312-AEA","Siponimod fumarate","Siponimod fumaric acid","Siponimod hemifumarate","Siponimod hemifumaric acid"],"crossReferences":{"DailyMed":["siponimod%20fumaric%20acid"]},"linkedTargets":{"rows":["ENSG00000170989"],"count":1},"linkedDiseases":{"rows":["EFO_0003840","MONDO_0005301","EFO_0003929","EFO_0008522"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 3 approved indications."}
{"id":"CHEMBL4298190","drugType":"Cell","blackBoxWarning":false,"name":"OMIDUBICEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Nicord"],"synonyms":["Cultured fraction, CF","Omidubicel"],"description":"Cell drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4302413","drugType":"Protein","blackBoxWarning":false,"name":"COPPER OXODOTREOTIDE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4297339"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for neuroendocrine neoplasm."}
{"id":"CHEMBL435381","canonicalSmiles":"COc1ccc(-c2c(Cl)ncn2-c2ccc(S(N)(=O)=O)cc2)cc1F","inchiKey":"KYXDNECMRLFQMZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIMICOXIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cimalgex","Cimicoxib","Cimicoxib (ema epar: veterinary)"],"crossReferences":{"drugbank":["DB05095"],"chEBI":["76127"]},"linkedTargets":{"rows":["ENSG00000073756"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL440510","canonicalSmiles":"CC(C)OC(=O)c1cc(NC(=S)OC(C)C)ccc1Cl","inchiKey":"AXTNFJKQZPETJA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL440510","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["494463"],"drugbank":["DB08681"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4437054","canonicalSmiles":"CS(=O)(=O)CCCn1c(Cn2c(=O)n(CC(F)(F)F)c3ccncc32)cc2cc(Cl)ccc21","inchiKey":"GTQTUABHRCWVLL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RILEMATOVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jnj-53718678","Rilematovir"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL450895","canonicalSmiles":"C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2","inchiKey":"VQOXZBDYSJBXMA-NQTDYLQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NYSTATIN","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Barstatin 100","Candex","Infestat","Korostatin","Multilind","Myco 20","Mycostatin","Mykinac","Nilstat","Nysert","Nyspes","Nystaform","Nystan triple pack","Nystatin","Nystavescent","Nystex","Nystop","Tinaderm m"],"synonyms":["L-nystatin","Mikostatin","NSC-150817","Nystatin","Nystatinum","Terrastatin"],"crossReferences":{"DailyMed":["nystatin"]},"childChemblIds":["CHEMBL3109319"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and is indicated for infection and candidiasis and has 18 investigational indications."}
{"id":"CHEMBL451","canonicalSmiles":"CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1","inchiKey":"ANTSCNMPPGJYLG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CHLORDIAZEPOXIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clopoxide","Librelease","Libritabs","Librium","Sarlib","Trakipeal","Zeisin"],"synonyms":["A-Poxide","Chlordiazachel","Chlordiazepoxide","Chlordiazepoxide civ","Clopoxide","Librium","Lygen"],"crossReferences":{"DailyMed":["chlordiazepoxide","chlordiazepoxide%20hydrochloride"],"PubChem":["144205120","144205121","49648393"],"Wikipedia":["Chlordiazepoxide"],"drugbank":["DB00475"],"chEBI":["3611"]},"childChemblIds":["CHEMBL1200703"],"linkedTargets":{"rows":["ENSG00000182256","ENSG00000022355","ENSG00000011677","ENSG00000163285","ENSG00000113327","ENSG00000151834","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0004777","EFO_0006788","MONDO_0002009","MONDO_0007079","EFO_0005230"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and has 3 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL452076","canonicalSmiles":"COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1","inchiKey":"KJEBULYHNRNJTE-DHZHZOJOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CILNIDIPINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atelec","Cilnidipine","Cinalong","FRC-8653","Siscard"],"crossReferences":{"PubChem":["144205554","170465867","26755677","50111041","90341030"],"drugbank":["DB09232"],"chEBI":["31399"]},"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067"],"count":4},"linkedDiseases":{"rows":["EFO_0000319","EFO_1001496","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL455136","canonicalSmiles":"CNC(=O)[C@@H](c1ccccc1)N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc1ccc(C(F)(F)F)cc1","inchiKey":"DKMACHNQISHMDN-RPLLCQBOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALMOREXANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACT-078573","Almorexant"],"crossReferences":{"Wikipedia":["Almorexant"],"drugbank":["DB06673"]},"childChemblIds":["CHEMBL3542330"],"linkedTargets":{"rows":["ENSG00000137252","ENSG00000121764"],"count":2},"linkedDiseases":{"rows":["EFO_0004698"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594455","drugType":"Unknown","blackBoxWarning":false,"name":"AGS-16C3F","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADC AGS-16C3F","AGS-16C3F","Ags-16c3f","Ags-16c3f (anti-enpp3 antibody)"],"linkedTargets":{"rows":["ENSG00000154269","ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["EFO_0000681","EFO_0000349"],"count":2},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650488","drugType":"Antibody","blackBoxWarning":false,"name":"ETESEVIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-sars-cov-2 antibody js016","CB6","Etesevimab","JS-016","JS016","LY COV016","LY-3832479","LY-COV016","LY3832479","Ly3832479","NP-005","NP005"],"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL476413","canonicalSmiles":"[11CH3]Oc1ccc(-c2c(C#N)c(C(=O)NN3CCCCC3)nn2-c2ccc(Cl)cc2Cl)cc1","inchiKey":"MCNQUWLLXZZZAC-BJUDXGSMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JHU-75528 C-11","maximumClinicalTrialPhase":0,"parentId":"CHEMBL514215","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["11c-jhu 75528","11c-omar","Jhu-75528 c-11","Omar c-11","[11C]NIDA41020"],"crossReferences":{"drugbank":["DB14902"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL500","canonicalSmiles":"CC(C)NCC(O)COc1cccc2[nH]ccc12","inchiKey":"JZQKKSLKJUAGIC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PINDOLOL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betadren","Pindolol","Visken"],"synonyms":["(rs)-pindolol","Apo-pindol","Betapindol","Blocklin-l","Calvisken","Carvisken","Decreten","Dl-lb-46","Dl-pindolol","Durapindol","Glauco-visken","LB-46","NSC-757276","Pectobloc","Pinbetol","Pindolol","Prinodolol","Pynastin"],"crossReferences":{"DailyMed":["pindolol"],"PubChem":["104171209","144203772","170464892","26747148","26747149","26752014","50104680","50104681","85231175","855790","90341348"],"Wikipedia":["Pindolol"],"drugbank":["DB00960"],"chEBI":["8214"]},"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["MONDO_0002050","MONDO_0002009","EFO_0003761","EFO_0000319"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for cardiovascular disease and has 2 investigational indications."}
{"id":"CHEMBL511115","canonicalSmiles":"COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1","inchiKey":"CFBUZOUXXHZCFB-OYOVHJISSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CILOMILAST","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ariflo","Cilomilast","SB 207499","SB-207499"],"crossReferences":{"PubChem":["144206070"],"Wikipedia":["Cilomilast"],"drugbank":["DB03849"]},"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000184588"],"count":4},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL529","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O","inchiKey":"MQTOSJVFKKJCRP-BICOPXKESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZITHROMYCIN","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azasite","Azithromycin","Azyter","Clamelle","Sumamed","Sunamed","ZMax","Zithromax"],"synonyms":["Anhydrous azithromycin","Aruzilina","Aziromycin","Azithrocin","Azithromycin","Azithromycin (as dihydrate)","Azithromycin anhydrous","Azithromycin dihydrate","Azithromycin hydrate","Azithromycin, unspecified","Azithromycin, unspecified form","Aziwin","CP 62993","CP-62,993","CP-62993","Durasite","Hemomycin","Macrozit","NSC-758625","Sumamed","Trozocina","XZ 405","XZ 450","XZ-450","Xithrone","Zithromac","Zythromax"],"crossReferences":{"DailyMed":["azithromycin"],"PubChem":["144204559","144208209","17389173","49648620"],"Wikipedia":["Azithromycin"],"drugbank":["DB00207"],"chEBI":["2955"]},"childChemblIds":["CHEMBL1200502"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 19 approved and 61 investigational indications."}
{"id":"CHEMBL55214","canonicalSmiles":"NCCCCCC(O)(P(=O)(O)O)P(=O)(O)O","inchiKey":"PUUSSSIBPPTKTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NERIDRONIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ahhexbp","Neridronate","Neridronic acid"],"crossReferences":{"drugbank":["DB11620"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL559","canonicalSmiles":"N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O","inchiKey":"XUIIKFGFIJCVMT-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROTHYROXINE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Thyroxine"],"synonyms":["Choloxin","D-thyroxine","Dextrothyroxine","Liotrix"],"crossReferences":{"PubChem":["11112110"],"Wikipedia":["Dextrothyroxine"],"drugbank":["DB00509"],"chEBI":["30659"]},"childChemblIds":["CHEMBL1200777","CHEMBL3545058"],"linkedTargets":{"rows":["ENSG00000126351","ENSG00000151090"],"count":2},"linkedDiseases":{"rows":["EFO_1001375","EFO_0001064","EFO_0000319","EFO_0000612"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for cardiovascular disease and has 3 investigational indications."}
{"id":"CHEMBL561639","canonicalSmiles":"O=C(c1ccc(OC[C@H]2CCCN2)cc1)c1ccc(-c2ccsc2)cc1","inchiKey":"VUWFJUJWAWMRQN-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL561639","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07237"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL591665","canonicalSmiles":"O=C1O[C@H]([C@@H](O)CO)C([O-])=C1O.[Na+]","inchiKey":"PPASLZSBLFJQEF-RXSVEWSESA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM ASCORBATE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ascorbin","Cevalin","Sodium Ascorbate"],"synonyms":["Ascorbic acid sodium salt","E-301","E301","INS NO.301","INS-301","Sodium ascorbate"],"crossReferences":{"DailyMed":["sodium%20ascorbate"],"PubChem":["144210873"],"Wikipedia":["Sodium_ascorbate"],"drugbank":["DB14482"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL617","canonicalSmiles":"CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3cccs3)[C@H]2SC1","inchiKey":"XIURVHNZVLADCM-IUODEOHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEPHALOTHIN","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefalotin","Cephalothin","Seffin"],"crossReferences":{"PubChem":["144205132","170465101","29215241","47193756","90341219"],"TG-GATEs":["141"],"Wikipedia":["Cefalotin"],"drugbank":["DB00456"],"chEBI":["124991"]},"childChemblIds":["CHEMBL1632"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974 and is indicated for bacterial disease."}
{"id":"CHEMBL661","canonicalSmiles":"Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2","inchiKey":"VREFGVBLTWBCJP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ALPRAZOLAM","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alprazolam","Niravam","Xanax","Xanax xr"],"synonyms":["Alprazolam","Alprazolam civ","NSC-760140","U 31,889","U-31,889","U-31889"],"crossReferences":{"DailyMed":["alprazolam"],"PubChem":["144205245","26719699","29215419"],"Wikipedia":["Alprazolam"],"drugbank":["DB00404"],"chEBI":["2611"]},"linkedTargets":{"rows":["ENSG00000182256","ENSG00000022355","ENSG00000011677","ENSG00000163285","ENSG00000151834","ENSG00000113327","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0004262","EFO_0006788","HP_0000726","EFO_1001884","EFO_0001358","HP_0001250","EFO_1001917","MONDO_0005277","EFO_1001892","EFO_0000474","EFO_0003890","MONDO_0002050","MONDO_0005147","MONDO_0004979","EFO_0005230"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 4 approved and 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL66879","canonicalSmiles":"O=C(O)/C=C/c1ccc(O)cc1","inchiKey":"NGSWKAQJJWESNS-ZZXKWVIFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COUMARIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["P-Coumaric Acid"],"crossReferences":{"PubChem":["47193719"],"Wikipedia":["P-Coumaric_acid"],"drugbank":["DB04066"],"chEBI":["32374"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL695","canonicalSmiles":"CN1C(=O)OC(C)(C)C1=O","inchiKey":"IRYJRGCIQBGHIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETHADIONE","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tridione"],"synonyms":["A 2297","Absentol","Epidione","J2.519D","Minoaleviatin","NSC-15799","NSC-169503","Tridone","Trimethadione","Trimethadionum","Troxidone"],"crossReferences":{"PubChem":["11112276","144203959","144207429"],"TG-GATEs":["122"],"Wikipedia":["Trimethadione"],"drugbank":["DB00347"]},"linkedTargets":{"rows":["ENSG00000100346","ENSG00000006283","ENSG00000196557"],"count":3},"linkedDiseases":{"rows":["EFO_0000474"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1946 and is indicated for epilepsy."}
{"id":"CHEMBL834","canonicalSmiles":"NCCC(O)(P(=O)(O)O)P(=O)(O)O","inchiKey":"WRUUGTRCQOWXEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAMIDRONIC ACID","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CGP-23339AE","Pamidronate","Pamidronic Acid","Pamidronic acid","Ribodroat"],"crossReferences":{"DailyMed":["pamidronate%20disodium"],"PubChem":["144205217","170464689","29215372","29217620"],"Wikipedia":["Pamidronic_acid"],"drugbank":["DB00282"]},"childChemblIds":["CHEMBL676","CHEMBL3989401"],"linkedTargets":{"rows":["ENSG00000160752"],"count":1},"linkedDiseases":{"rows":["HP_0000938","EFO_0003898","MONDO_0007254","HP_0003419","EFO_0000706","EFO_0001378","EFO_0004260","Orphanet_666","EFO_0003882","EFO_1001164"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for bone disease and has 6 investigational indications."}
{"id":"CHEMBL855","canonicalSmiles":"Cc1ccc(/C(=C\\CN2CCCC2)c2ccccn2)cc1","inchiKey":"CBEQULMOCCWAQT-WOJGMQOQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIPROLIDINE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Actahist","Actidil","Actifed","Allerfed","Corphed","Histafed","Myfed","Myidyl","Trilitron","Triphed","Triprolidine"],"crossReferences":{"DailyMed":["triprolidine%20hydrochloride"],"PubChem":["144204470","170464931","26751829","50104523","50104524","50104525","90341007"],"Wikipedia":["Triprolidine"],"drugbank":["DB00427"],"chEBI":["84116"]},"childChemblIds":["CHEMBL1200450","CHEMBL3188034"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","MONDO_0005271","HP_0001742","EFO_0007214","EFO_0003956"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and has 5 approved indications."}
{"id":"CHEMBL93836","canonicalSmiles":"CCCC(CCC)C(N)=O","inchiKey":"OMOMUFTZPTXCHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALPROMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Depamide","Valpromide"],"crossReferences":{"PubChem":["144206685"],"Wikipedia":["Valpromide"],"drugbank":["DB04165"],"chEBI":["74562"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL99946","canonicalSmiles":"CCN(CC)C(=O)[C@@]1(c2ccccc2)C[C@H]1CN","inchiKey":"GJJFMKBJSRMPLA-DZGCQCFKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LEVOMILNACIPRAN","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fetzima"],"synonyms":["(1s,2r)-milnacipran","F 2695","F-2695","F2695","Levomilnacipran","Milnacipran, (1s,2r)-"],"crossReferences":{"DailyMed":["levomilnacipran%20hydrochloride"],"drugbank":["DB08918"]},"childChemblIds":["CHEMBL2105732"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_0005687","HP_0002140","MONDO_0002009","EFO_0003768","EFO_0003761"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 3 approved and 3 investigational indications. This drug has a black box warning from the FDA."}
